Last Updated

19 Jul 2021

Risk factors of malaria infection across the China-Myanmar border and the problem of radical cure of vivax


This study aims to identify the risk factors for malaria infection in the border areas, determining the epidemiological characteristics of malaria across China-Myanmar border and defining hotspots/'hotpops' by using case-control methodologies.
In addition, the efficacy, safety, tolerance and compliance of drug treatments will also be assessed through randomized clinical trials.

Rationale and Abstract

Control of malaria importation and radical treatment of Plasmodium vivax are two difficulties in malaria-eliminating settings. The control of communicable diseases along borders is one of the cooperation areas agreed in the fifth Health Minister summit of the Association of Southeast Asian Nations.
The outcomes of this study will provide scientific evidence and technical support for the reduction of malaria importation in China, and help identify infection sources in order to interrupt malaria transmission in the border areas. On the other hand, these outcomes will be useful for keeping the status of malaria elimination and control of other infectious diseases across the borders.